Quoin Pharmaceuticals, Ltd. (QNRX) Stock Analysis & Investment Frameworks
Quoin Pharmaceuticals, Ltd. (QNRX) stock analysis on Invetso. Review Quoin Pharmaceuticals, Ltd.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Quoin Pharmaceuticals, Ltd. Company Overview
- Exchange: NASDAQ Capital Market
- Sector: Healthcare
- Industry: Biotechnology
- Country: US
Quoin Pharmaceuticals, Ltd. Key Financial Metrics
- Market Cap: $6.93M
- Revenue: $N/A
- ROE: -144.38%
- ROIC: -50.78%
- Dividend Yield: N/A
About Quoin Pharmaceuticals, Ltd.
Quoin Pharmaceuticals, Ltd. operates as a specialized pharmaceutical firm, concentrating its efforts on devising therapeutic solutions for rare and orphan medical conditions. Its flagship offering, QRX003, is a topical lotion specifically formulated to address Netherton Syndrome. Furthermore, the company is advancing QRX004 for the management of dystrophic epidermolysis bullosa, alongside QRX006, a prospective therapy for an additional rare dermatological ailment. The organization maintains its operational base in Ashburn, Virginia.
Quoin Pharmaceuticals, Ltd. Investment Frameworks
Invetso analyzes Quoin Pharmaceuticals, Ltd. (QNRX) across the following frameworks:
- Quoin Pharmaceuticals, Ltd. 10Y Growth Potential
- Quoin Pharmaceuticals, Ltd. Scenario Analysis
- Quoin Pharmaceuticals, Ltd. Risks & Opportunities
- Quoin Pharmaceuticals, Ltd. Economic Moat
- Quoin Pharmaceuticals, Ltd. Business Model
- Quoin Pharmaceuticals, Ltd. Management
- Quoin Pharmaceuticals, Ltd. SWOT Analysis
- Quoin Pharmaceuticals, Ltd. Porter's 5 Forces
- Quoin Pharmaceuticals, Ltd. PESTLE Analysis
- Quoin Pharmaceuticals, Ltd. ESG Analysis